Delivery Order SPE2DB24D2205-SPE2DB25FDYCS
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $11,588.58, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a firm fixed-price pricing type and a completion date of June 13, 2024. Amerisourcebergen Drug Corp also holds an Indefinite Delivery...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract has a ceiling value of $19,735.38 and an ultimate completion date of January 26, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. This contract is not designated as a set-aside....
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products to the Defense Logistics Agency (DLA). The contract, valued at $4,647.12, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the Defense Logistics Agency (DLA). The $17,414.44 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 14, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $6,031.75 and is a firm fixed-price delivery order that runs through January 30, 2024. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has a ceiling value of $10,724.78 and an ultimate completion date of May 11, 2023. This is a Firm Fixed Price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $15,300.94 and a period of performance through December 28, 2023. The contract is not designated with a set-aside. Amerisourcebergen...
This federal contract award, valued at $11,020.54, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a completion date of December 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $27,366.66, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of May 7, 2024. This award is not associated with a set-aside designation, indicating open...
This federal contract award, valued at $37,251.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a completion date of December 3, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....